Pharmacokinetic-based multi-organ chip for recapitulating organ interactions

Area of Science:

• Biomedical Engineering
• Pharmacology
• Toxicology

Background:

• Organ-on-a-chip (OOC) technology offers superior in vitro modeling capabilities compared to traditional cell-based systems.
• Emerging diseases often involve intricate multi-organ interactions, necessitating advanced research models.
• Pharmacokinetic (PK) models are essential for understanding molecular transport and reactions within biological systems.

Purpose of the Study:

• To review diverse organ-on-a-chip device designs, focusing on multi-organ systems.
• To introduce pharmacokinetic (PK) modeling concepts.
• To elucidate the application of PK models in designing and analyzing multi-organ chip devices.

Main Methods:

• Review of existing literature on organ-on-a-chip devices.
• Discussion of multi-organ chip configurations.
• Explanation of pharmacokinetic modeling principles and their integration with OOC technology.

Main Results:

• Organ-on-a-chip technology enables the recreation of physiological functions and multi-organ interactions in vitro.
• Multi-organ chip devices are effective for modeling complex diseases.
• Pharmacokinetic models provide a framework for analyzing and designing these advanced in vitro systems.

Conclusions:

• Organ-on-a-chip technology, particularly multi-organ devices, holds significant promise for disease modeling.
• Integrating pharmacokinetic models enhances the predictive power of OOC systems for understanding complex biological processes.
• This approach facilitates the development of more accurate in vitro models for drug development and disease research.